Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 10
2004 12
2005 6
2006 13
2007 11
2008 14
2009 20
2010 19
2011 17
2012 31
2013 30
2014 30
2015 27
2016 17
2017 7
2018 10
2019 23
2020 25
2021 31
2022 18
2023 11
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

350 results

Results by year

Filters applied: . Clear all
Page 1
Complex bio rhythms.
Akgul A, Savi MA, Yildiz MZ, Sanjuan MAF, Ma J. Akgul A, et al. Among authors: yildiz mz. Eur Phys J Spec Top. 2022;231(5):815-818. doi: 10.1140/epjs/s11734-022-00540-7. Epub 2022 Apr 20. Eur Phys J Spec Top. 2022. PMID: 35464296 Free PMC article.
Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial.
Özkan M, Gündüz S, Gürsoy OM, Karakoyun S, Astarcıoğlu MA, Kalçık M, Aykan AÇ, Çakal B, Bayram Z, Oğuz AE, Ertürk E, Yesin M, Gökdeniz T, Duran NE, Yıldız M, Esen AM. Özkan M, et al. Among authors: yildiz m. Am Heart J. 2015 Aug;170(2):409-18. doi: 10.1016/j.ahj.2015.04.025. Epub 2015 May 2. Am Heart J. 2015. PMID: 26299240 Clinical Trial.
Stent thrombosis--mythy and facts.
Yildiz M, Yildiz BS, Aydin E, Akin I. Yildiz M, et al. Cardiovasc Hematol Disord Drug Targets. 2014;14(3):231-4. doi: 10.2174/1871529x14666140825094456. Cardiovasc Hematol Disord Drug Targets. 2014. PMID: 25174712 Review.
Recent developments in drug-eluting coronary stents.
Yildiz M, Yildiz BS, Gursoy MO, Akin I. Yildiz M, et al. Cardiovasc Hematol Disord Drug Targets. 2014;14(3):220-4. doi: 10.2174/1871529x14666140823121609. Cardiovasc Hematol Disord Drug Targets. 2014. PMID: 25174714 Review.
Uni-leaflet mitral valve.
Candan O, Guler A, Aung SM, Gecmen C, Karabay CY, Yildiz M. Candan O, et al. Among authors: yildiz m. Eur J Echocardiogr. 2011 Aug;12(8):640. doi: 10.1093/ejechocard/jer027. Epub 2011 Mar 16. Eur J Echocardiogr. 2011. PMID: 21414956 No abstract available.
Triple antiplatelet therapy after PCI--should or could it be done?
Yildiz BS, Yildiz M, Aydin E, Akin I. Yildiz BS, et al. Among authors: yildiz m. Cardiovasc Hematol Disord Drug Targets. 2014;14(3):235-9. doi: 10.2174/1871529x14666140825095243. Cardiovasc Hematol Disord Drug Targets. 2014. PMID: 25174711 Review.
Interaction between thienopyridines and proton pump inhibitors.
Yildiz BS, Yildiz M, Akin I. Yildiz BS, et al. Among authors: yildiz m. Cardiovasc Hematol Disord Drug Targets. 2014;14(3):240-5. doi: 10.2174/1871529x14666140823121002. Cardiovasc Hematol Disord Drug Targets. 2014. PMID: 25163670 Review.
350 results